Cargando…
Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production
BACKGROUND: Vitamin D is a key immune-modulator that plays a role in the innate and adaptive immune systems. Certain pathogens impair the immune defense by downregulating the vitamin D receptor (VDR) pathway. Low serum levels of vitamin D are associated with increased hepatitis B virus (HBV) replica...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192355/ https://www.ncbi.nlm.nih.gov/pubmed/30326825 http://dx.doi.org/10.1186/s10020-018-0055-0 |
_version_ | 1783363894945775616 |
---|---|
author | Gotlieb, Neta Tachlytski, Irena Lapidot, Yelena Sultan, Maya Safran, Michal Ben-Ari, Ziv |
author_facet | Gotlieb, Neta Tachlytski, Irena Lapidot, Yelena Sultan, Maya Safran, Michal Ben-Ari, Ziv |
author_sort | Gotlieb, Neta |
collection | PubMed |
description | BACKGROUND: Vitamin D is a key immune-modulator that plays a role in the innate and adaptive immune systems. Certain pathogens impair the immune defense by downregulating the vitamin D receptor (VDR) pathway. Low serum levels of vitamin D are associated with increased hepatitis B virus (HBV) replication. Our study aimed to assess the in-vitro relationship between HBV production and Vitamin D signaling pathway and to explore the associated mechanism(s). METHODS: HBV transcription and replication was evaluated by qRT-PCR of the HBV-RNA and covalently closed circular DNA (cccDNA). Furthermore, we have transfected the 1.3 X HBV-Luc plasmid to the cells and measured the Luciferase activity using Luminometer. Vitamin D signaling pathway activation was evaluated by measuring the expression levels of VDR, CYP24A1, Tumor necrosis factor α (TNFα) and cathelicidin (CAMP) by qRT-PCR. All assays were performed on HepG2.2.15, HepG2, and HepAD38 cells treated with or without Vitamin D active metabolite: calcitriol. RESULTS: Calcitriol did not suppress HBV transcription, cccDNA expression or HBV RNA levels in HepG2.2.15 cells. However, VDR transcript levels in HepG2.215 cells were significantly lower compared to HepG2 cells. Similar results were obtained in HepAD38 cell where VDR expression was down-regulated when HBV transcript level was up-regulated. In addition, calcitriol induced VDR-associated signaling, resulting in upregulation of CYP24A1, TNFα and CAMP expression level in HepG2 cells but not in the HepG2.2.15 cells. CONCLUSIONS: These findings indicate that VDR expression is downregulated in HBV-transfected cells, thereby preventing vitamin D from inhibiting transcription and translation of HBV in vitro. HBV might use this mechanism to avoid the immunological defense system by affecting both TNFα and CAMP signaling pathways. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s10020-018-0055-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6192355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61923552018-10-31 Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production Gotlieb, Neta Tachlytski, Irena Lapidot, Yelena Sultan, Maya Safran, Michal Ben-Ari, Ziv Mol Med Research Article BACKGROUND: Vitamin D is a key immune-modulator that plays a role in the innate and adaptive immune systems. Certain pathogens impair the immune defense by downregulating the vitamin D receptor (VDR) pathway. Low serum levels of vitamin D are associated with increased hepatitis B virus (HBV) replication. Our study aimed to assess the in-vitro relationship between HBV production and Vitamin D signaling pathway and to explore the associated mechanism(s). METHODS: HBV transcription and replication was evaluated by qRT-PCR of the HBV-RNA and covalently closed circular DNA (cccDNA). Furthermore, we have transfected the 1.3 X HBV-Luc plasmid to the cells and measured the Luciferase activity using Luminometer. Vitamin D signaling pathway activation was evaluated by measuring the expression levels of VDR, CYP24A1, Tumor necrosis factor α (TNFα) and cathelicidin (CAMP) by qRT-PCR. All assays were performed on HepG2.2.15, HepG2, and HepAD38 cells treated with or without Vitamin D active metabolite: calcitriol. RESULTS: Calcitriol did not suppress HBV transcription, cccDNA expression or HBV RNA levels in HepG2.2.15 cells. However, VDR transcript levels in HepG2.215 cells were significantly lower compared to HepG2 cells. Similar results were obtained in HepAD38 cell where VDR expression was down-regulated when HBV transcript level was up-regulated. In addition, calcitriol induced VDR-associated signaling, resulting in upregulation of CYP24A1, TNFα and CAMP expression level in HepG2 cells but not in the HepG2.2.15 cells. CONCLUSIONS: These findings indicate that VDR expression is downregulated in HBV-transfected cells, thereby preventing vitamin D from inhibiting transcription and translation of HBV in vitro. HBV might use this mechanism to avoid the immunological defense system by affecting both TNFα and CAMP signaling pathways. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s10020-018-0055-0) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-16 /pmc/articles/PMC6192355/ /pubmed/30326825 http://dx.doi.org/10.1186/s10020-018-0055-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Gotlieb, Neta Tachlytski, Irena Lapidot, Yelena Sultan, Maya Safran, Michal Ben-Ari, Ziv Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production |
title | Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production |
title_full | Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production |
title_fullStr | Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production |
title_full_unstemmed | Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production |
title_short | Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production |
title_sort | hepatitis b virus downregulates vitamin d receptor levels in hepatoma cell lines, thereby preventing vitamin d-dependent inhibition of viral transcription and production |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192355/ https://www.ncbi.nlm.nih.gov/pubmed/30326825 http://dx.doi.org/10.1186/s10020-018-0055-0 |
work_keys_str_mv | AT gotliebneta hepatitisbvirusdownregulatesvitamindreceptorlevelsinhepatomacelllinestherebypreventingvitaminddependentinhibitionofviraltranscriptionandproduction AT tachlytskiirena hepatitisbvirusdownregulatesvitamindreceptorlevelsinhepatomacelllinestherebypreventingvitaminddependentinhibitionofviraltranscriptionandproduction AT lapidotyelena hepatitisbvirusdownregulatesvitamindreceptorlevelsinhepatomacelllinestherebypreventingvitaminddependentinhibitionofviraltranscriptionandproduction AT sultanmaya hepatitisbvirusdownregulatesvitamindreceptorlevelsinhepatomacelllinestherebypreventingvitaminddependentinhibitionofviraltranscriptionandproduction AT safranmichal hepatitisbvirusdownregulatesvitamindreceptorlevelsinhepatomacelllinestherebypreventingvitaminddependentinhibitionofviraltranscriptionandproduction AT benariziv hepatitisbvirusdownregulatesvitamindreceptorlevelsinhepatomacelllinestherebypreventingvitaminddependentinhibitionofviraltranscriptionandproduction |